| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |